These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26206713)

  • 1. Trial design innovations: Clinical trials for treatment of neuropsychiatric symptoms in Alzheimer's Disease.
    Cummings J; Zhong K
    Clin Pharmacol Ther; 2015 Nov; 98(5):483-5. PubMed ID: 26206713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical syndrome of Alzheimer's disease: aspects particularly relevant to clinical trials.
    Mohs RC
    Genes Brain Behav; 2005 Apr; 4(3):129-33. PubMed ID: 15810901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes.
    Di Iulio F; Palmer K; Blundo C; Casini AR; Gianni W; Caltagirone C; Spalletta G
    Int Psychogeriatr; 2010 Jun; 22(4):629-40. PubMed ID: 20367890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of neuropsychiatric symptoms in young-onset compared to late-onset Alzheimer's disease - part 1: findings of the two-year longitudinal NeedYD-study.
    van Vliet D; de Vugt ME; Aalten P; Bakker C; Pijnenburg YA; Vernooij-Dassen MJ; Koopmans RT; Verhey FR
    Dement Geriatr Cogn Disord; 2012; 34(5-6):319-27. PubMed ID: 23208452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease.
    Waldemar G; Gauthier S; Jones R; Wilkinson D; Cummings J; Lopez O; Zhang R; Xu Y; Sun Y; Knox S; Richardson S; Mackell J
    Int J Geriatr Psychiatry; 2011 Feb; 26(2):150-7. PubMed ID: 20597141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer's disease.
    Wang HJ; Chinna-Meyyappan A; Feldman OJ; Lanctôt KL
    Expert Opin Emerg Drugs; 2024 Sep; 29(3):289-303. PubMed ID: 38822731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apathy Treatment in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.
    Rea R; Carotenuto A; Traini E; Fasanaro AM; Manzo V; Amenta F
    J Alzheimers Dis; 2015; 48(2):377-83. PubMed ID: 26402001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a serotonin reuptake inhibitor on irritability, apathy, and psychotic symptoms in patients with Alzheimer's disease.
    Siddique H; Hynan LS; Weiner MF
    J Clin Psychiatry; 2009 Jun; 70(6):915-8. PubMed ID: 19422762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Development for Psychotropic, Cognitive-Enhancing, and Disease-Modifying Treatments for Alzheimer's Disease.
    Cummings J
    J Neuropsychiatry Clin Neurosci; 2021; 33(1):3-13. PubMed ID: 33108950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches to symptomatic treatments for Alzheimer's disease.
    Cummings J
    Mol Neurodegener; 2021 Jan; 16(1):2. PubMed ID: 33441154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP).
    Takemoto M; Ohta Y; Hishikawa N; Yamashita T; Nomura E; Tsunoda K; Sasaki R; Tadokoro K; Matsumoto N; Omote Y; Abe K
    J Alzheimers Dis; 2020; 76(2):769-772. PubMed ID: 32568205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild cognitive impairment: a treatment at last?
    Allain H; Bentué-Ferrer D; Akwa Y
    Lancet Neurol; 2004 Nov; 3(11):643. PubMed ID: 15488455
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlations among cognitive and behavioural assessments in patients with dementia due to Alzheimer's disease.
    de Oliveira FF; Wajman JR; Bertolucci PH; Chen ES; Smith MC
    Clin Neurol Neurosurg; 2015 Aug; 135():27-33. PubMed ID: 26010393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future.
    Geda YE; Schneider LS; Gitlin LN; Miller DS; Smith GS; Bell J; Evans J; Lee M; Porsteinsson A; Lanctôt KL; Rosenberg PB; Sultzer DL; Francis PT; Brodaty H; Padala PP; Onyike CU; Ortiz LA; Ancoli-Israel S; Bliwise DL; Martin JL; Vitiello MV; Yaffe K; Zee PC; Herrmann N; Sweet RA; Ballard C; Khin NA; Alfaro C; Murray PS; Schultz S; Lyketsos CG;
    Alzheimers Dement; 2013 Sep; 9(5):602-8. PubMed ID: 23562430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's type.
    Pinto T; Lanctôt KL; Herrmann N
    Ageing Res Rev; 2011 Sep; 10(4):404-12. PubMed ID: 21292041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer's and Parkinson's Diseases.
    Van der Schyf CJ
    Drug Dev Res; 2016 Dec; 77(8):458-468. PubMed ID: 27813127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterase inhibitors: A new class of psychotropic compounds.
    Cummings JL
    Am J Psychiatry; 2000 Jan; 157(1):4-15. PubMed ID: 10618007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of citalopram in the treatment of agitation in Alzheimer's disease.
    Porsteinsson AP; Keltz MA; Smith JS
    Neurodegener Dis Manag; 2014; 4(5):345-9. PubMed ID: 25405648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.
    Harry RD; Zakzanis KK
    Hum Psychopharmacol; 2005 Apr; 20(3):183-7. PubMed ID: 15700322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.